Abstract
Pruritus is prevalent in 5–12% of palliative care patients. Rifampicin has been shown to be useful both as initial treatment and as salvage treatment after failure of other agents to control the pruritus associated with the cholestatic jaundice of malignancy. We report the case of a 65-year-old woman who complained of severe pruritus after morphine treatment. The use of rifampicin 300 mg twice a day by the i.v. route was successful, and after opioid switching it was no longer necessary to maintain rifampicin in the therapeutic regimen. Controlled clinical trials are warranted to confirm this preliminary observation.
Author information
Authors and Affiliations
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Mercadante, S., Villari, P. & Fulfaro, F. Rifampicin in opioid-induced itching. Support Care Cancer 9, 467–468 (2001). https://doi.org/10.1007/s005200000227
Published:
Issue Date:
DOI: https://doi.org/10.1007/s005200000227